CD4 expression decrease by antisense oligonucleotides: inhibition of rat T CD4+ cell reactivity.
In previous studies, we have demonstrated the inhibition of CD4 expression in rat lymphocytes treated with phorbol myristate acetate (PMA) by antisense oligonucleotides (AS-ODNs) directed against the AUG start region of the cd4 gene. The aim of the present study was to inhibit CD4 expression in lymphocytes without promoting CD4 synthesis and to determine the effect of this inhibition on CD4+ T cell function. Four 21-mer ODNs against the rat cd4 gene (AS-CD4-1 to AS-CD4-4) were used. Surface CD4 expression was measured by immunofluorescence staining and flow cytometry, and mRNA CD4 expression was measured by RT-PCR. T CD4+ cell function was determined by specific and unspecific proliferative response of rat-primed lymphocytes. After 24 hours of incubation, AS-CD4-2 and AS-CD4-4 reduced lymphocyte surface CD4 expression by 40%. This effect remained for 72 hours and was not observed on other surface molecules, such as CD3, CD5, or CD8. CD4 mRNA expression was reduced up to 40% at 24 hours with AS-CD4-2 and AS-CD4-4. After 48 hours treatment, CD4 mRNA decreased up to 27% and 29% for AS-CD4-2 and AS-CD4-4, respectively. AS-CD4-2 and AS-CD4-4 inhibited T CD4+ cell proliferative response upon antigen-specific and unspecific stimuli. Therefore, AS-ODNs against CD4 molecules inhibited surface and mRNA CD4 expression, under physiologic turnover and, consequently, modulate T CD4+ cell reactivity.
Rabanal
Manel
M
Department of Physiology-Division IV, Faculty of Pharmacy, University of Barcelona, Spain.
Franch
Angels
A
Noé
Véronique
V
Pelegrí
Carme
C
Ciudad
Carlos J
CJ
Castellote
Cristina
C
Castell
Margarida
M
D000818:Animals; D015704:CD4 Antigens / Q000096:biosynthesis / Q000235:genetics* / Q000276:immunology; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000378:metabolism*; D049109:Cell Proliferation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D005229:Fatty Acids, Monounsaturated; D005260:Female; D015870:Gene Expression / Q000187:drug effects*; D008213:Lymphocyte Activation / Q000187:drug effects*; D016376:Oligonucleotides, Antisense / Q000494:pharmacology*; D000644:Quaternary Ammonium Compounds; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar
D015704:CD4 Antigens; D005229:Fatty Acids, Monounsaturated; D016376:Oligonucleotides, Antisense; D000644:Quaternary Ammonium Compounds; D012333:RNA, Messenger; C070046:1,2-dioleoyloxy-3-(trimethylammonium)propane